Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oops! US FDA's Paperwork Submission Failure Leaves Audit Fixes Overdue

Executive Summary

The FDA did not submit the form the Office of Inspector General needed to resolve audit findings, meaning two years of recommendations were considered overdue.

You may also be interested in...

US FDA Headquarters Parking Problem May Create Security Risk

GAO report says vehicle security system needs to be implemented, details challenges for employees handling sensitive information due to office sharing.

FDA resolves audit issues

FDA has resolved outstanding audit recommendations and installed a protocol to resolve future recommendations according to a Feb. 15 1report from the Health and Human Services Office of Inspector General (OIG). OIG found that "FDA did not have reasonable assurance that it was exercising proper stewardship over Federal dollars" because, as of Dec. 31, 2005, the agency had not resolved eight audit recommendations out of 314 from 16 audit reports during calendar years 2003-2005. OIG says 287 of those 306 resolved were not completed within the required six months...

Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?

Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise, but is there an appetite for another reorganization?


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts